𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mutation and Protein Expression Biomarkers Correlate with Response to AKT Inhibition in a Phase I Trial of the Oral Pan AKT Inhibitor GSK2141795 (GSK795) in Patients (pts) with Platinum Resistant Ovarian Cancer

✍ Scribed by H. Gunqor; E. Stronach; E. Curry; A. Saleem; R. Agarwal; S. Blagden; S. Babar; G. Mills; S.R. Morris; H. Gabra


Book ID
117660622
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
62 KB
Volume
47
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.